Patent Assignment
Reel/Frame 068757/0957
Merger
Recorded: 2024-10-01
Pages: 16
Assignor
SUMITOMO PHARMA ONCOLOGY, INC.
Executed: 2023-09-15
Assignee
SUMITOMO PHARMA AMERICA, INC.
84 WATERFORD DRIVE, MARLBOROUGH, MASSACHUSETTS, 01752
Covered Property
(1)
Pim Kinase Inhibitors for Treatment of Myeloproliferative Neoplasms and Fibrosis Associated with Cancer
Application:
18/743,075 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →
Assignment of Assignor's Interest
Oct 1, 2024
From: FOULKS, JASON MARC; WARNER, STEVEN L.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 069094/0174 →
Change of Name
Oct 1, 2024
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 069094/0181 →
Change of Name
Oct 1, 2024
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 069095/0329 →
Merger
Oct 1, 2024
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 068757/0850 →